XBIO reported its FY2024Q3 earnings on 2024-11-12, showcasing a revenue of 614.00K against an estimate of 746.00K, resulting in a -17.71% surprise. The EPS was -0.28, surpassing the expected -0.14 by -100% . The stock experienced a 4.56% price change on the earnings day and a -0.25% change over the next five days, reflecting market reactions to the results.